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The thymus does not contain self-renewing T 
cell progenitors (TCPs) and, therefore, requires 
continuous  importation  of  progenitors  from 
the blood to sustain T cell output (1, 2). Re-
cruitment of TCPs to the thymus is facilitated 
by a multistep adhesion cascade initiated by the 
interaction of P-selectin glycoprotein ligand 1 
(PSGL-1) expressed on TCPs, with P-selectin 
(CD62P) expressed on thymic endothelium 
(3, 4). Specific N-terminal carbohydrate modifi-
cations on PSGL-1 catalyzed by glycosyltrans-
ferases are required for binding to P-selectin.   
In particular, the activity of the core 2 1,6-
glucosaminyltransferase-I (C2GnT1) has been 
highlighted in selectin ligand formation on 
PSGL-1 (5). Interaction of PSGL-1 with endo-
thelial P-selectin slows down TCPs, and allows 
them to respond to local chemokine gradients 
and to engage the endothelial adhesion mole-
cules intercellular adhesion molecule 1 (ICAM-1) 
and vascular cell adhesion molecule 1 (VCAM-1) 
via integrins, leading to a firm arrest of TCPs 
on the thymic endothelium (4).
Thymic TCP importation is independent 
of the numbers of available TCPs in the blood 
(6) and is not a steady-state process, as the thy-
mus alternates between nonreceptive and recep-
tive periods (2). This suggests that a feedback 
mechanism regulates expression of recruitment 
signals on vascular or perivascular cells. One fac-
tor proposed to control progenitor entry into the 
thymus is the limited availability of intrathymic 
niches for which TCPs compete and, thus, gain 
access to survival and differentiation factors nec-
essary for their development (6). Full thymic 
niches are thought to trigger a feedback signal 
to reduce TCP importation, but the nature of 
these feedback signals and how they influence 
thymic TCP entry is unknown.
To explore the basis of feedback signals that 
determine periodicity in thymic TCP receptivity, 
we analyzed the expression of adhesion mole-
cules in WT mice and mouse strains with distinct 
thymic receptivities. We found that thymic P-
selectin and CCL25 expression correlated with 
thymic TCP receptivity, suggesting that these 
molecules function as thymic gatekeepers. Fur-
thermore, we found that P-selectin expression 
and thymic TCP receptivity correlated inversely 
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or  only  modest  increased  thymic  receptivity.  In  contrast, 
RAG-1/ thymi had a reduced receptivity.
The short-term assay cannot be used to determine whether 
the thymi import truly functional TCPs to various degrees, 
because neither the exact nature of the TCP population in 
the blood that seeds the thymus under physiological condi-
tions nor the intrathymic TCP population that contributes 
predominantly to T cell formation is yet known (7). Long-
term thymus reconstitution experiments in nonirradiated 
recipients were thus used to evaluate whether the observed 
increased short-term receptivity in IL-7R/ and PSGL-1/ 
mice corresponded to an increased contribution of injected 
donor bone marrow to thymocyte formation. 3 wk after bone 
marrow transfer, the long-term reconstitution experiments 
showed that IL-7R/ mice had the highest chimerism 
(79 × 106 donor-derived DP thymocytes), and that there was 
a significant increase in the numbers of donor-derived DP 
thymocytes in PSGL-1/ and C2GnT1/ mice (38 × 106 
and 20 × 106, respectively) when compared with WT recipients 
(4.2 × 106 donor-derived DP thymocytes; Fig. 1 e), whereas 
thymi of RAG-1/ mice had significantly lower numbers 
(4.4 × 105) of donor-derived DP thymocytes (Fig. 1 e), in 
agreement with the data from the short-term homing assays.
P-selectin and CCL25 expression correlate  
with thymic TCP importation
To determine whether differences in thymic P-selectin ex-
pression could explain differences in thymic receptivity, we 
measured P-selectin RNA expression by quantitative real-time 
PCR (qrtPCR) on whole thymic tissues. Thymic P-selectin 
expression is restricted to endothelial cells (3). Thus, P-selec-
tin RNA was normalized using the endothelial-specific marker 
vascular endothelial–cadherin (VE-cadherin) to exclude a 
skewing of the data because of differences in thymic size and 
relative endothelial content. P-selectin RNA levels were high 
in IL-7R/ and PSGL-1/ thymi when compared with WT 
thymi (Fig. 2 a). P-selectin RNA levels were also increased 
in C2GnT1/ thymi but were 4.5-fold lower than in 
PSGL-1/ thymi, whereas RAG-1/ mice had significantly 
reduced thymic P-selectin RNA. Control experiments showed 
that P-selectin RNA levels in spleens were comparable in all 
mouse strains, demonstrating that altered P-selectin expression 
was thymus specific (Fig. 2 b).
To confirm that increased P-selectin RNA levels are as-
sociated with elevated P-selectin protein levels on thymic en-
dothelial cells, we analyzed thymic endothelial cells (CD45, 
CD31+, CD144+) by flow cytometry. PSGL-1/ and IL-
7R/ mice had a two- and fourfold increased frequency of 
Pselhi-expressing endothelial cells, respectively, when com-
pared with WT controls (Fig. 2 c). In C2GnT1/ thymi, P-
selectin protein expression was comparable to WT controls, 
whereas it was significantly reduced on endothelial cells from 
RAG-1/ thymi.
In addition to P-selectin, the integrin ligands ICAM-1 and 
VCAM-1 and the chemokine CCL25 are known to support 
thymic TCP importation (4). To assess whether expression of 
with peripheral lymphocyte numbers and could be manipu-
lated by experimentally altering peripheral lymphocyte numbers. 
These results show that the peripheral lymphocyte pool feeds 
back to thymic TCP entry sites and modifies thymic TCP 
importation by regulating P-selectin and CCL25 expression.
RESULTS
Thymi of PSGL-1/ and IL-7R/ mice are hyperreceptive 
for TCPs
We showed previously that P-selectin is functionally involved 
in thymic TCP importation and that thymic P-selectin RNA 
expression reversely correlated with thymic niche occupancy 
status (3). To further characterize the relationship of thymic 
P-selectin expression and TCP receptivity, we used two 
complementary approaches to assess thymic TCP receptivity 
in mice deficient for IL-7R, RAG-1, C2GnT1, PSGL-1, 
or Psel. Short-term homing assays were performed to deter-
mine the capacity of thymi to import i.v. injected CFSE-
labeled bone marrow cells from the blood stream. Long-term 
reconstitutions of nonirradiated hosts were performed to de-
termine the contribution of i.v. injected bone marrow cells to 
the host’s double-positive (DP) thymocyte pool.
Short-term receptivity of thymi was expressed as a ratio 
of homed cells to thymic cell numbers (Fig. 1, a and b), or per 
milligram of thymic weight (Fig. 1 c), to eliminate a skewing 
of the data because of variations in thymic size in the different 
mouse strains analyzed (Fig. S1). When expressed as ratio of 
the number of homed CFSE+ cells per 2 × 106 thymocytes, our 
data show that IL-7R/ thymi import fourfold more CFSE+ 
cells than WT mice (Fig. 1 a). PSGL-1/ mice also show 
significantly increased receptivity for CFSE+ bone marrow cells, 
whereas C2GnT1/ thymi did not show an increased re-
ceptivity when compared with WT mice. Receptivity in 
RAG-1/ thymi was nonsignificantly reduced compared 
with WT mice.
Short-term homing data displayed as a ratio of homed lin-
eage marker (Lin: CD3, CD4, CD8, CD19, Gr-1, CD11b, 
CD11c, Ter119, NK, and /TCR)–negative CFSE+ cells 
per 2 × 106 thymocytes demonstrated that IL-7R/ mice 
showed an almost 30-fold increased thymic receptivity com-
pared with WT mice (Fig. 1 b); PSGL-1/ and C2GnT1/ 
mice had an 8- and 2-fold increased receptivity, respectively, 
whereas receptivity in RAG-1/ mice was reduced. When 
data were expressed as numbers of CFSE+ cells per milligram 
of thymic tissue, IL-7R/ thymi were again found to be the 
most receptive, with 80 CFSE+ cells per milligram of thy-
mus, followed by PSGL-1/ and C2GnT1/ thymi, with 
60 and 40 CFSE+ cells per milligram of thymic tissue, respec-
tively (Fig. 1 c). In contrast, RAG-1/ mice showed signifi-
cantly (P < 0.001) reduced receptivity when compared with 
WT controls. The numbers of CFSE+ cells per milliliter of 
blood was similar in all mouse strains, confirming that differ-
ences in thymic importation are not caused by differences of 
injected donor cells in the blood (Fig. 1 d). Collectively, this 
set of data shows that IL-7R/ and PSGL-1/ thymi have 
increased receptivity, whereas C2GnT1/ mice showed no JEM VOL. 206, April 13, 2009 
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qrtPCR analysis performed on sorted thymic endothelial, 
cortical epithelial, and medullary epithelial cells confirmed that 
P-selectin and the reference gene VE-cadherin were exclu-
sively expressed in thymic endothelial cells (CD45, CD31+, 
CD144+) and were absent in cortical epithelial cells (CD45, 
Ly51hi, G8.8+) or medullary epithelial cells (CD45, Ly51int, 
G8.8+; Fig. 3 b). ICAM-1 and VCAM-1 were expressed in 
endothelial and epithelial cells. ICAM-1 was expressed highest 
these molecules is similarly regulated to P-selectin expression, 
we compared RNA levels in the thymi of WT and the previ-
ously mentioned mouse strains. We found significantly increased 
levels of CCL25 RNA in the thymi of IL-7R/ and PSGL-
1/ mice and, to a lower degree, in the thymi of Psel/ mice 
when compared with WT thymi (Fig. 3 a). C2GnT1/ mice 
showed similar CCL25 expression as WT mice. ICAM-1 and 
VCAM-1 RNA levels were comparable in all tested strains.
Figure 1.  Thymic receptivity in WT, RAG-1/, C2GnT1/, PSGL-1/, and IL-7R/ mice in short- and long-term reconstitution assays.  
(a–d) 24 h after i.v. injection of CFSE-labeled nonfractionated bone marrow cells, mice were sacrificed, and thymi and peripheral blood (PBL) were analyzed for 
CFSE+ cells. (a) Absolute numbers of CFSE+ cells per 2 × 106 thymocytes recovered from the thymi of the indicated mouse strains. (b) Absolute numbers of 
LinCFSE+ cells per 2 × 106 thymocytes recovered from thymi of the indicated mouse strains. (c) Absolute numbers of CFSE+ cells per milligram of thymus weight 
(wet wt) of the indicated mouse strains. (d) Absolute numbers of CFSE+ cells present in 1 ml PBL in the indicated mouse strains. (e) Absolute numbers of donor-
derived DP thymocytes 3 wk after i.v. injection of congenic bone marrow into the indicated mouse strains. Data are representative of three independent ex-
periments with at least six mice per group (means ± SEM). Mice were sex matched and 35 ± 3 d old. C2, C2GnT1. *, P < 0.05; **, P < 0.01; and ***, P < 0.001.764 LYMPHOCYTE HOMEOSTASIS CONTROLS THYMIC TCP IMPORTATION | Gossens et al.
in endothelial cells, whereas the highest VCAM-1 expression 
was found in medullary epithelial cells. Furthermore, we found 
that CCL25 RNA levels were highest in endothelial cells, 
followed by medullary epithelial and cortical epithelial cells. 
Because the numbers of endothelial cells in the thymi of the 
different mouse strains were comparable (Fig. 3 c), skewing 
of our data caused by variations in thymic cell composition 
can be excluded.
Collectively, our data demonstrate that thymi with high 
receptivity for TCPs express elevated levels of P-selectin 
and CCL25, supporting the idea that these molecules are 
not only functionally involved in thymic TCP importation 
but might also be involved in regulating this process by dif-
ferential expression.
P-selectin/CCL25 RNA is expressed periodically over time  
in WT but not in PSGL-1/ or C2GnT1/ thymi
Thymic progenitor importation periodically alternates between 
nonreceptive and receptive phases (2). Should P-selectin and 
CCL25 regulate TCP entry, we would expect these molecules 
to be expressed in an oscillating manner. We determined thy-
mic P-selectin and CCL25 RNA expression in mice ranging in 
age from 12 to 68 d. In WT mice, P-selectin RNA expression 
was periodic, whereas P-selectin RNA levels remained rela-
tively constant over time in C2GnT1/ and PSGL-1/ mice 
(Fig. 4, a–c). P-selectin RNA baseline levels were only slightly 
increased in C2GnT1/ mice (1.5-fold) compared with 20-d-
old WT controls but were significantly increased (4-fold) in 
PSGL-1/ thymi. P-selectin expression in the spleens of WT, 
PSGL-1/, or C2GnT1/ mice remained relatively constant 
over time, suggesting that the observed periodicity is specific 
for the WT thymus (Fig. S2). In WT mice, the temporal thy-
mic expression pattern of CCL25 RNA was similar to that 
observed for P-selectin (Fig. 4 d). Plotting the mean expression 
level of P-selectin as a function of mean CCL25 level at the same 
time  points  showed  that  P-selectin  RNA  expression  highly   
correlated with CCL25 expression (P < 0.001; Pearson’s  = 
0.607; Fig. 4 e). Thymic CCL25 RNA expression again lacked 
periodicity in C2GnT1/ and PSGL-1/ mice, where it was 
expressed at relatively constant levels with only minor periodic 
changes. Similar to the observation for thymic P-selectin,   
CCL25 RNA levels were considerably higher in PSGL-1/ 
thymi than in C2GnT1/ thymi (Fig. 4 f).
Thymic niche occupancy is not the only factor limiting 
thymic receptivity
We next sought to identify the feedback signals that regulate   
thymic P-selectin/CCL25 expression and thymic TCP receptiv-
ity. It has been shown that competition for intrathymic niches, 
especially at the triple-negative (TN; all are LinloCD4CD8, 
with TN1 CD44+CD25, TN2 CD44CD25+, and pre-DP 
CD44CD25) TN2 and TN3 stages, limits TCP entry into 
the thymus (8). To test this model, we reconstituted nonir-
radiated IL-7R/ mice with FACS-sorted TN1, TN2, or 
TN3 WT thymocytes and measured thymic P-selectin ex-
pression and chimerism in the thymus and blood 12 d later 
Figure 2.  Thymic P-selectin expression is increased in hyperrecep-
tive thymi of IL-7R/ and PSGL-1/ mice. P-selectin RNA expres-
sion determined by qrtPCR in (a) thymi and (b) spleens of mice of the 
indicated mouse strains. RNA levels were normalized to VE-cadherin ex-
pression and expressed relative to WT (=1, as indicated). (c) Frequencies of 
Pselhi-expressing cells within the thymic endothelial cell population (de-
fined as CD45, CD144+, CD31+) in thymic cell suspensions derived from 
WT, RAG-1/, C2GnT1/, PSGL-1/, and IL-7R/ mice, as deter-
mined by flow cytometry. Data are representative of three independent 
experiments with at least six mice per group in a and b, and at least three 
mice per group in c (means ± SEM). Mice were sex matched and 37 ± 2 d 
old. C2, C2GnT1. *, P < 0.05; **, P < 0.01; and ***, P < 0.001.JEM VOL. 206, April 13, 2009 
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fore compared content and distribution of thymocyte subsets 
in WT, PSGL-1/, C2GnT1/, and Psel/ thymi. TN 
thymocyte subset distributions were surprisingly similar in 
WT and all three knockout strains (Fig. 5 b). However, the 
size of the early TCP (ETP; Linlo, CD117hi, Sca-1+, CD44+, 
CD25) (9) population that is believed to contain the earliest 
intrathymic TCPs was reduced by 45–85% in the thymi of 
C2GnT1/, PSGL-1/, and Psel/ mice (Fig. 5 c). Given 
that the total thymic cellularity and the numbers of thymocyte 
subsets in knockout thymi are similar to WT thymi (Fig. S1),   
we hypothesized that the size of intrathymic niches may be 
(Fig. 5 a; and Fig. S3, a and b). Injection with each TN subset 
led to thymic reconstitution and the formation of peripheral 
T cells (Fig. S3, a, d, and e), which was accompanied by a 
significant reduction in thymic P-selectin RNA when com-
pared with the vehicle-treated controls (Fig. 5 a). TN3 cells 
did not give rise to TN1 or TN2 cells (Fig. S3 c), indicating 
that TN3 cells and their progeny are sufficient to control thy-
mic receptivity. These data are consistent with the niche oc-
cupancy model, and we thus expected that the differences in 
thymic receptivities that we observed in our study were also 
caused by differences in thymic niche occupancy. We there-
Figure 3.  CCL25 RNA is expressed in thymic endothelial cells and is also highly expressed in hyperreceptive thymi of IL-7R/ and PSGL-
1/ mice. (a) RNA levels of ICAM-1, VCAM-1, and CCL25 in the thymi of WT and RAG-1/, C2GnT1/, PSGL-1/, IL-7R/, and Psel/ mice, as deter-
mined by qrtPCR. RNA levels were normalized to VE-cadherin and HPRT expression and expressed relative to WT (=1, as indicated). (b) Relative expression 
of the indicated genes in FACS-sorted WT thymic endothelial cells (ENDO; CD45, CD31+, CD144+), cortical epithelial cells (CEC; CD45, Ly51hi, G8.8+), and 
medullary epithelial cells (MEC; CD45, Ly51int, G8.8+) relative to expression in an unsorted sample. RNA levels were normalized to the reference genes 
HPRT and TbP. N.D., not detected. (c) Numbers of ENDO, CEC, and MEC in the thymi of the indicated mouse strains. For b and c, thymi were sequentially 
digested with collagenase and collagenase/dispase, and single-cell suspensions were analyzed by flow cytometry using reference beads to calculate abso-
lute cell numbers. ENDO, CEC, and MEC were defined as in b. Data are representative of at least three independent experiments with at least five mice in a 
and c, and four mice in b (means ± SEM). Mice were sex matched and 35 ± 4 d old. C2, C2GnT1. *, P < 0.05; **, P < 0.01; and ***, P < 0.001.766 LYMPHOCYTE HOMEOSTASIS CONTROLS THYMIC TCP IMPORTATION | Gossens et al.
Figure 4.  P-selectin and CCL25 RNA are periodically regulated in WT thymi. P-selectin RNA level as a function of time in (a) WT, (b) C2GnT1/, 
or (c) PSGL-1/ mice, as determined by qrtPCR, were normalized to VE-cadherin expression and expressed relative to WT values at 20 d of age (=1, as 
indicated). (d) Temporal expression of thymic P-selectin and CCL25 RNA as determined by qrtPCR using the reference genes VE-cadherin and HPRT in WT 
mice. (e) Scatter plot showing P-selectin expression as a function of CCL25 expression in the same samples used in d. The diagonal line shows linear re-
gression. Thymic P-selectin expression and CCL25 RNA show a highly significant (P < 0.001) correlation (Pearson’s  = 0.607). (f) Temporal thymic CCL25 
RNA level as determined by qrtPCR normalized using the reference genes VE-cadherin and HPRT in WT, PSGL-1/, and C2GnT1/ mice. Expression levels JEM VOL. 206, April 13, 2009 
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Peripheral lymphocyte levels affect thymic TCP receptivity
To test for the potential effect of peripheral T cell lymphope-
nia on thymic P-selectin expression, we compensated the re-
duced  peripheral  T  cell  numbers  in  PSGL-1/  mice  by 
transfer of 20 × 106 WT lymphocytes. 2 d after lymphocyte 
transfer,  thymic  P-selectin  expression  and  receptivity  for 
TCPs was reduced by 50–60% when compared with saline-
injected controls (Fig. 7, a and b; and Fig. S5 a).
These observations suggested that depletion of peripheral 
T cells might lead to increased P-selectin expression and, thus, 
increased thymic progenitor receptivity. To test this hypothe-
sis, we depleted peripheral CD4 and CD8 T cells in WT mice 
with anti-CD4 and -CD8 antibodies, whereas thymic T cell 
numbers remained unchanged (Fig. S5 b). Both thymic P-se-
lectin RNA and TCP receptivity increased nearly threefold 
within 24 h after T cell depletion when compared with sa-
line-treated controls (Fig. 7, c and d). Collectively, these data 
support the hypothesis that thymic TCP importation can be 
altered by changes in peripheral lymphocyte levels.
Thymic P-selectin expression correlates  
with plasma S1P levels
Aside from its role in lymphocyte egress from lymphoid organs, 
S1P is involved in the regulation of endothelial barrier function 
and the expression of endothelial adhesion molecules, includ-
ing P-selectin (13–16), making this lipid metabolite a potential 
candidate to affect thymic endothelial P-selectin expression.
To test whether S1P levels vary under physiological con-
ditions, we used liquid chromatography–mass spectrometry/
mass spectrometry (LC-MS/MS) to determine S1P levels in 
the plasma of WT and the previously mentioned mouse 
strains. We found that IL-7R/ and RAG-1/ mice had 
S1P plasma levels comparable to WT controls. S1P was mod-
erately reduced in PSGL-1/ mice (23%; P = 0.044) and 
slightly but not significantly reduced in C2GnT1/ mice 
(10%; P = 0.349) when compared with WT controls. In con-
trast, Psel/ mice had increased S1P plasma levels (26%; P = 
0.033) compared with WT (Fig. 8 a).
Given that thymic P-selectin expression is periodically ex-
pressed in WT thymi, we tested whether plasma S1P levels were 
also changing periodically and, if so, whether S1P levels   
correlated with thymic P-selectin RNA. S1P plasma levels 
varied in 19–65-d-old WT mice within a range of 2–3.7 µM. 
Changes in plasma S1P concentration correlated positively 
and significantly (P < 0.001) with changes in thymic P-selectin 
RNA (Fig. 8, b and c), suggesting that S1P plasma level and 
thymic P-selectin expression are linked.
S1P agonist FTY720 reduces thymic P-selectin expression
S1P has been shown to induce RNA expression of VCAM-1 and 
E-selectin in human endothelial cells mediated by NF-B (13).   
similar in WT and knockout thymi. To test whether dif-
ferences in the occupation status of intrathymic niches could 
explain the observed differences in receptivity we intrathy-
mically injected WT bone marrow cells into the thymi of the 
different knockout strains. We found significantly (three to   
five times) increased availability of intrathymic niche space in 
mice deficient for PSGL-1, P-selectin, or C2GnT1 (Fig. 5 d).   
Niche availability inversely correlated with thymic ETP con-
tent and was comparable in C2GnT1/ and PSGL-1/ 
thymi (Fig. 5, c and d), contrasting with the significant differ-
ences observed between these two mouse strains in short- and 
long-term receptivity, and pointing to additional mechanisms 
next to niche occupancy that are involved in the regulation 
of thymic TCP receptivity.
Thymic emigration of single-positive (SP) T cells is impaired 
in PSGL-1/ mice
We next considered the possibility that mature thymocyte 
subsets or thymic T cell export rates might influence TCP 
receptivity. Thus, we examined whether T cell production in 
PSGL-1/ and C2GnT1/ mice was different from WT 
mice. Cell-surface marker analysis of maturing thymocyte 
subsets showed increased frequencies of semimature (CD24+, 
CD69+, CD62Llo, Qa-2) and mature (CD24lo, CD69, Lselhi, 
Qa-2+) (10–12) CD4+ and CD8+ thymocytes in PSGL-1/ 
thymi (Fig. 6 a) but not in C2GnT1/ thymi when com-
pared with WT controls. qrtPCR analysis of FACS-sorted   
mature (CD44lo, CD62Lhi, Qa-2+) CD8+ and CD4+ thymo-
cytes revealed a significant increase in RNA levels of T cell 
maturation  markers  (sphingosine-1-phosphate  [S1P]–lyase, 
the transcription factor KLF2, and its target S1P1; Fig. S4, a–c), 
confirming a high maturation status of accumulated SP thy-
mocytes in PSGL-1/ thymi, suggesting impaired thymic emi-
gration in these mice.
We used intrathymic FITC injections as well as quantiza-
tion of T cell receptor excision circles (TRECs) to measure 
thymic exit rates and found, consistent with these observa-
tions, that mature PSGL-1/ T cells leave the thymus at a 
significantly lower rate than WT T cells, whereas C2GnT1/ 
T cells emigrated at a rate comparable to WT T cells (Fig. 6, 
b and c).
The reduced thymic output in PSGL-1/ mice was fur-
thermore associated with decreased T cells in the periphery. 
In PSGL-1/ mice, we found significantly reduced numbers 
of CD4 and CD8 cells in peripheral blood, whereas T cell 
numbers in C2GnT1/ mice were comparable to WT con-
trols (Fig. 6 d). Reduced thymic T cell output together with 
reduced numbers of peripheral T cells in PSGL-1/ mice 
led us to hypothesize that thymic T cell output and/or the 
size of the peripheral lymphocyte pool might modulate thy-
mic P-selectin expression and, thus, TCP receptivity.
are expressed relative to the corresponding value found in WT thymi at 20 d of age (=1, as indicated). Data in a–c show a combination of three out of a 
total of five independent experiments; data in d and f are representative of at least five independent experiments (means ± SEM). For all time-course 
experiments, at least four mice per time point were used. Only female mice were used in time-course experiments. C2, C2GnT1.
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creases P-selectin expression on thymic endothelium in vivo, 
we treated IL-7R/ mice, which have a normal level of 
plasma S1P (Fig. 8 a) and only few T and B cells, for 3 d with 
the S1P analogue FTY720 (19). Treatment of IL-7R/ mice 
with FTY720 significantly reduced thymic P-selectin RNA 
expression (Fig. 9 b). Treatment of WT mice with FTY720 
also resulted in a reduction of thymic P-selectin expression and 
was associated with reduced thymic TCP receptivity (Fig. 9, 
c and d), suggesting that S1PR signaling is involved in the 
regulation of thymic P-selectin expression and, thus, thymic 
TCP  receptivity.  Furthermore,  mice  treated  for  3  d  with 
FTY720 had significantly (P = 0.002) reduced DN1 thymo-
cyte numbers compared with controls (Fig. S6, a and b). Col-
lectively, this set of data shows that FTY720 treatment reduces 
thymic TCP entry.
Because both mouse E- and P-selectin promotor regions 
share transcription factor binding sites, including those for 
NF-B and activating transcription factor (ATF) (17), S1P 
receptor (S1PR) signaling could potentially also modulate 
P-selectin expression. One hallmark of S1PR signaling is its 
concentration dependency; superphysiological levels of S1P 
often inhibit the very same processes that are activated under 
lower concentrations (18). S1P treatment of the mouse endo-
thelial cell line bend.3 showed that S1P can directly modulate 
P-selectin expression in endothelial cells (Fig. 9 a). Concen-
trations up to 1 µM S1P had a significant positive effect on 
P-selectin RNA expression when compared with control cells, 
whereas a superphysiological concentration of S1P (10 µM) 
significantly reduced P-selectin expression below control 
values. To determine whether an increased S1P level also de-
Figure 5.  The niche occupancy model does not explain differences in thymic TCP receptivity between C2GnT1/ and PSGL-1/ mice.  
(a) TN1–3 thymocyte subsets were purified by FACS and i.v. injected into nonirradiated IL-7R/ mice. The figure shows the thymic P-selectin RNA level  
as determined by qrtPCR using the reference gene VE-cadherin 12 d after injection. P-selectin levels are expressed relative to sex- and age-matched WT 
mice (=1, as indicated). *, P < 0.05, significantly reduced P-selectin expression relative to vehicle-injected control. (b) Numbers of TN thymocyte subsets 
are similar in the thymi of WT and C2GnT1/, PSGL-1/, and Psel/ mice. TN cells were defined as Linlo, CD4, CD8, with TN1 (CD25CD44+), TN2 
(CD25+CD44+), TN3 (CD25+CD44), and pre-DP (CD25CD44). (c) Numbers of ETPs (Linlo, CD44+, CD25, cKithi Sca-1+) are significantly reduced in 
C2GnT1/, PSGL-1/, and P-selectin–deficient mice when compared with WT mice. (d) Numbers of donor-derived cells 14 d after intrathymic injection 
of WT bone marrow cells are increased in C2GnT1/, PSGL-1/, and Psel/ mice compared with WT controls. Data are representative of three indepen-
dent experiments with at least four mice used in a, and at least seven mice used in b–d (means ± SEM). Mice were sex matched and 45 ± 4 d old in a, and 
35 ± 4 d old in b–d. C2, C2GnT1. *, P < 0.05; **, P < 0.01; and ***, P < 0.001.JEM VOL. 206, April 13, 2009 
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cells, B cells, or a 1:1 mixture of T and B cells was associated 
with a reduction in plasma S1P levels 3 d after cell transfer.   
B cells reduced S1P levels by 40%, T cells reduced S1P levels 
by 34%, and the T and B cell mixture reduced S1P levels by 
47% (Fig. 10 b). Collectively, this set of data shows that short-
term perturbation of peripheral lymphocyte numbers can in-
duce changes in plasma S1P levels that in turn might be 
linked to control of thymic P-selectin expression.
DISCUSSION
P-selectin and CCL25 are known to facilitate TCP entry into 
the thymus, and thymic P-selectin expression has been shown 
to correlate with thymic TCP receptivity (2–4, 21). In this 
study, we extend the knowledge about the regulation of TCP 
entry into the thymus and provide evidence that P-selectin 
and CCL25 themselves are regulated in a temporal and quan-
titative manner. Most TCPs described so far express functional 
To examine whether local tissue S1P gradients or overall 
plasma S1P levels modulate P-selectin expression, we treated 
mice with 2-deoxypyridoxine (DOP) to inhibit the S1P-
degrading enzyme S1P-lyase, thereby increasing S1P levels in 
lymphoid tissues but not in blood, disrupting the S1P gradient 
between lymphoid tissues and blood or lymph (20). Adminis-
tration of DOP resulted in a significant reduction of thymic 
P-selectin RNA and TCP receptivity, suggesting that disrup-
tion of the S1P gradient associated with a local increase of S1P 
in lymphoid tissues leads to down-regulation of thymic P-
selectin and TCP receptivity (Fig. 9, e and f; and Fig. S7).
Finally, we analyzed whether changes in P-selectin ex-
pression after lymphocyte boost and depletion were associ-
ated with corresponding changes in plasma S1P levels. 48 h 
after depletion of CD4 and CD8 T cells, S1P levels were in-
creased by 34% when compared with saline-injected controls 
(P = 0.052; Fig. 10 a). Boosting PSGL-1/ mice with T 
Figure 6.  PSGL-1 deficiency is associated with reduced thymic T cell output and peripheral T cell lymphopenia. (a) Flow cytometry analysis of 
CD4 and CD8 SP thymocytes, and semimature (CD24+, CD69+, Qa-2, Lsello) and mature (CD24lo, CD69, Qa-2+, Lselhi) CD4+ and CD8+ thymocyte subsets 
in WT, C2GnT1/, and PSGL-1/ mice. (b) Total numbers of FITC+, Lselhi, CD4+ and FITC+, Lselhi, CD8+ T cells in lymph nodes and spleen of WT, C2GnT1/ 
and PSGL-1/ mice 36 h after intrathymic FITC injection. (c) Numbers of TRECs per 106 spleen-derived T cells in WT, C2GnT1/, and PSGL-1/ mice as 
measured by qrtPCR. (d) Numbers of CD4+ or CD8+ cells per microliter of peripheral blood in age-matched WT, C2GnT1/, and PSGL-1/ mice. Data are 
representative of three (a, b, and d) and two (c) independent experiments, with at least four mice per group in a–c and three mice per group in d (means ± 
SEM). Mice were sex matched and 36 ± 4 d old. C2, C2GnT1. *, P < 0.05; and ***, P < 0.001.770 LYMPHOCYTE HOMEOSTASIS CONTROLS THYMIC TCP IMPORTATION | Gossens et al.
the thymi of IL-7R/ and PSGL-1/ mice likely also 
explains the relatively high importation of LinCFSE+ cells 
in the short-term homing assays.
Although the presence of homing molecules like P-selectin 
and CCL25 is important in regulating the quantity and quality 
of TCPs entering the thymus, deficiencies in these proteins can 
be compensated by functional redundancy among the homing 
molecules and by intrathymic compensatory mechanisms (24). 
We show that although PSGL-1/, C2GnT1/, and Psel/ 
mice have reduced ETP numbers, they have normal thymic 
cellularity, indicating that increased intrathymic proliferation 
can compensate for a lack in ETP numbers. Whether the 
T cells that result from compensatory proliferation of a re-
duced ETP pool are qualitatively identical to T cells that 
resulted from a large ETP pool remains to be investigated.
The temporal expression of thymic P-selectin we ob-
served is remarkably stable for the first 3 wk after birth and 
P-selectin ligands (7); regulation of thymic P-selectin expres-
sion thus offers an effective way to control TCP importation 
on a general level but does not provide specificity to the thy-
mic recruitment process. Chemokines are likely to provide 
specificity, and several studies have highlighted the role of 
CCL25 in TCP recruitment (4, 22, 23). We show that thy-
mic endothelial cells as well as epithelial cells produce CCL25 
RNA, and that thymic CCL25 is expressed periodically in 
parallel with P-selectin. Hence, high expression of CCL25 
should preferentially enhance the thymic homing of TCPs 
expressing high levels of CCR9. Such CCR9hi TCPs have 
been shown to be more efficient in producing T cells than 
their CCR9lo counterparts (22). The elevated levels of CCL25 
RNA in the thymi of PSGL-1/ mice are thus likely the 
explanation for the higher receptivity we observe in PSGL-1/ 
mice at time points when they express similar amounts of   
P-selectin as WT thymi. Increased expression of CCL25 in 
Figure 7.  Size of the peripheral lymphocyte pool modulates thymic P-selectin expression and thymic receptivity. (a) Thymic P-selectin RNA 
levels in PSGL-1/ mice were determined 2 d after i.v. transfer of 20 × 106 WT lymphocytes (boosted) or vehicle alone (control). (b) Numbers of donor-
derived DP thymocytes were determined by flow cytometry 3 wk after transfer of WT bone marrow into vehicle (control) or lymphocyte-injected (boosted) 
PSGL-1/ mice. (c) Thymic P-selectin RNA levels in WT mice 24 h after i.p. injection of anti-CD4/CD8 antibodies (depleted) or vehicle alone (control).  
(d) Numbers of donor-derived DP thymocytes were determined by flow cytometry 3 wk after bone marrow transfer into CD4/CD8 T cell–depleted (depleted) 
or control WT mice. Bone marrow transfers were performed on day 2 after boost or depletion. Data are representative of two independent experiments 
with at least six mice (means ± SEM). Mice were sex-matched and 42 ± 4 d old. RNA levels were normalized to VE-cadherin expression and expressed 
relative to values from vehicle-treated controls (=1, as indicated). *, P < 0.05.JEM VOL. 206, April 13, 2009 
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starts to oscillate around the time of weaning. The increase in 
P-selectin and CCL25 expression coincides with the second 
wave of postnatal TCPs that seed the thymus around days 
18–22 after birth (25), a period when the neonatal immune 
system is highly active and develops full independence of the 
maternal immune system (26). P-selectin was expressed with 
a periodicity of 2 wk, in agreement with an earlier study that 
found a 2-wk wave-like pattern of filling, occupation, and 
emptying of intrathymic niches (8). However, another study 
showed a periodicity for thymic receptivity of about 3–4 wk 
(2). This discrepancy could be caused by the use of nonsyn-
chronized mice in our work, whereas the earlier study used 
irradiation or intrathymic injection of bone marrow cells to 
synchronize the thymi of recipient mice.
One underlying cause of the periodic expression of thy-
mic P-selectin expression could be endothelial cell turnover. 
However, based on the longevity of endothelial cells, which 
is estimated to be in the range of months to years, it is un-
likely that cell turnover causes the cyclical P-selectin expres-
sion we observed (27). It is also unlikely that fluctuations in 
CCL25 expression are caused by a highly proliferative subset 
of medullary epithelial cells (28), as we also observed CCL25 
in cortical epithelial and, particularly, in endothelial cells that 
produce the bulk of thymic CCL25 RNA. Instead, our ob-
servations point to the occupation status of ETP niches as a 
regulator for the periodicity of homing molecule expression 
and thymic receptivity. We found that mice with perma-
nently contracted ETP pools lacked the periodicity of P-se-
lectin or CCL25, supporting a model whereby ETP numbers 
regulate the periodic expression of P-selectin and CCL25 via 
a negative feedback signal. In this model, full ETP niches 
would trigger a negative feedback to close the thymic gates 
and keep them closed for 2 wk, which is the time required 
for TCPs to reach the TN3 developmental stage (12, 24). 
ETPs reside anatomically close to their thymic entry sites in 
the perimedullary cortical regions and asynchronously mi-
grate from there deeper into the cortex (12). Given that the 
steady egress of cells from the ETP sites occurs at a constant 
rate, the shrinking ETP pool size could indeed function as a 
timer to prepare the TCP entry sites to up-regulate recruit-
ment molecules, enabling the next wave of TCPs to enter the 
thymus. Thus, in mice that lack functional P-selectin–PSGL-
1 interaction, TCP entry is impaired and occurs at a constant 
rate. Hence, ETP numbers in these mice do not change over 
time, leaving P-selectin and CCL25 levels relatively stable.
Although periodicity of thymic receptivity seems to be 
exclusively regulated by an internal negative feedback signal 
triggered by ETP numbers, we found that the amount of 
homing molecules expressed on the thymic endothelium is 
dynamically regulated by internal and external feedback sig-
nals. The occupation status of intrathymic niches supporting 
Figure 8.  Plasma S1P correlates with thymic P-selectin RNA ex-
pression over time in WT mice. (a) Plasma concentration of S1P in the 
indicated mouse strains as determined by LC-MS/MS. (b) Mean plasma 
S1P concentration (red) and relative mean thymic P-selectin expression 
(black) in 19–65-d-old WT mice. (c) Scatter plot showing P-selectin ex-
pression from b as a function of S1P plasma concentration (µM). The 
diagonal line shows linear regression. S1P plasma concentration and thy-
mic P-selectin RNA show a highly significant (P < 0.001) correlation 
(Pearson’s  = 0.735). Data in a are representative of three independent 
experiments with at least five sex-matched mice that were 34 ± 4 d old, 
and data in b and c are representative of two independent experiments 
with at least three mice per time point (means ± SEM). RNA levels were 
normalized to VE-cadherin expression and were expressed relative to 
values at day 19 (=1, as indicated). Only female mice were used for time-
course experiments. C2, C2GnT1. *, P < 0.05.
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Figure 9.  The immunomodulating drugs FTY720 and DOP alter endothelial P-selectin expression and thymic receptivity. (a) S1P dose–re-
sponse on P-selectin RNA expression in bend.3 cells that were cultured in the indicated concentrations of S1P for 12 h. Control wells received media only 
(n = 8). (b and c) Thymic P-selectin RNA levels were assessed by qrtPCR and normalized to the reference gene VE-cadherin in (b) IL-7R/ and (c) WT mice 
i.p. injected with 1 mg/kg FTY720 or vehicle alone on three consecutive days. (d) Numbers of donor-derived DP thymocytes 3 wk after bone marrow 
transfer into WT recipients that were treated for 3 d with FTY720 or vehicle alone. (e) Thymic P-selectin RNA levels in WT mice after treatment with  JEM VOL. 206, April 13, 2009 
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FTY720, but the physiological consequences of prolonged 
drug treatment remain to be investigated.
The finding that boosting or depleting peripheral lym-
phocyte numbers correlated with rapid changes in plasma 
S1P levels suggests that peripheral lymphocytes and S1P me-
tabolism  interact.  However,  it  remains  to  be  determined 
whether  lymphoyctes  directly  or  indirectly  modulate  S1P 
level. Our data also show that S1P levels in lymphopenic 
IL-7R/ and RAG-1/ mice were not increased com-
pared with WT mice, which seems to contradict the data 
from the boost/depletion experiments. We favor the expla-
nation that compensatory mechanisms described previously 
(34–36) might lead to normal S1P levels in those mice. P-se-
lectin or PSGL-1 deficiency is associated with altered blood 
S1P levels, indicating that the presence of these molecules 
is important in S1P homeostasis. It has been shown that   
P-selectin–deficient mice have an increased level of plasma 
high-density lipoprotein (HDL) (37). Because HDL binds 
free S1P, thereby protecting it from degradation (38), the 
increased S1P level we observe in Psel/ mice could be 
explained by increased plasma HDL. Furthermore, the phe-
notype of PSGL-1/ mice is to some degree reminiscent of 
the phenotype of sphingosine-kinase–deficient mice (35) in 
that both knockout strains have reduced S1P plasma levels 
and a corresponding increased S1P1 expression on T cells, re-
duced thymic output, and reduced numbers of circulating T 
cells, whereas T cells in lymph nodes and spleens are normal. 
Collectively, these findings suggest a possible interaction be-
tween  S1P  metabolism  and  the  P-selectin–PSGL-1  axis. 
However, the exact nature of this mechanism needs to be 
further investigated.
Boost/depletion experiments revealed a surprisingly rapid 
feedback mechanism in the regulation of thymic TCP entry. 
We hypothesize that boosting or depleting the peripheral T 
cell pool leads to increased cell stress that in turn could trigger 
an acute reaction leading to altered S1P level. In support of 
this hypothesis are the findings that S1P levels change under 
stress situation and inflammation (39–41). Furthermore, the 
observation that hematopoietic stem and progenitor cells also 
respond to S1P gradients (42, 43) suggests a potential bifunc-
tional role of S1P in modulating thymic TCP receptivity by 
altering adhesion molecule expression on the thymic endo-
thelium and by modulating the migration pattern of hemato-
poietic stem and progenitor cells, including TCPs.
How can lymphocytes, which are only marginally involved 
in S1P production or degradation (18, 44), induce short-term 
changes in S1P levels? There is clear evidence that erythro-
cytes are one major source for plasma S1P, and although ge-
netic evidence is still lacking, there are strong indications that 
DN3 thymocytes has been proposed previously as a mecha-
nism that could limit entry of new TCPs (6). Although 
reconstitution of IL-7R/ mice with TN3 cells was in 
agreement with such a mechanism, we found that C2GnT1/ 
and PSGL-1/ mice had the same DN thymocyte subset 
distribution and intrathymic niche availability but differed 
greatly in thymic TCP importation. This observation pointed 
to the existence of an additional mechanism, other than intra-
thymic niche occupancy, that regulates thymic Psel/CCL25 
expression and receptivity. Manipulation of the peripheral 
lymphocyte pool led, within a relatively short period of time, 
to significant changes in the intensity of thymic TCP impor-
tation, providing evidence for a rapid feedback mechanism 
between the peripheral lymphocyte pool and thymic TCP 
recruitment. Such a mechanism is absent in RAG-1/ mice 
that are lymphopenic but have thymi that are very low in   
P-selectin/CCL25 and TCP receptivity. Fundamental distur-
bances in thymic architecture noted previously in RAG-1/ 
mice may preclude formation of proper negative feedback 
mechanism (6, 29). Although the peripheral lymphocyte   
pool is able to alter the intensity of thymic TCP receptivity, 
our data do not indicate that it also affects the periodicity of 
P-selectin/CCL25 expression. Furthermore, homeostatic 
mechanisms maintain steady lymphocyte numbers over time 
(30), making it unlikely that the peripheral lymphocyte pool 
contributes to periodicity in thymic TCP importation.
Our analyses have uncovered two novel phenotypes as-
sociated with PSGL-1 deficiency, T cell lymphopenia, and a 
reduced exit rate of T cells from the thymus. We have shown 
previously that PSGL-1/ T cells have 10% reduced hom-
ing to the spleen (31); although this reduced homing capacity 
may marginally skew determination of the thymic exit rate of 
PSGL-1/ T cells, it is unlikely to translate in the 50% re-
duced exit rate we have determined for these cells.
We  identified  S1P  as  a  potential  mediator  translating 
changes in the peripheral lymphocyte pool into altered thy-
mic TCP receptivity. The phospholipid S1P is known to ac-
tivate the NF-B pathway through the S1P3 receptor (32) 
and to induce transcription of cytokines, chemokines, and 
adhesion molecules, including P-selectin (17, 33). Using the 
mouse endothelial cell line bend.3, we showed that S1P has 
an opposing dose-dependent effect on P-selectin expression, 
in agreement with a previous study performed on human 
cells (16), suggesting that S1P might act directly on endothelial 
cells and that the effects we observed in vivo are not caused 
by indirect effects. The observation that DOP treatment also 
inhibits thymic TCP receptivity suggests that local S1P gradi-
ents modulate TCP importation. Furthermore, our findings 
expand the known pharmacological activities of DOP and 
30 mg/liter DOP in the drinking water for 3 d. (f) Numbers of donor-derived DP thymocytes as determined by flow cytometry 3 wk after bone marrow trans-
fer into WT mice treated for 3 d with 30 mg/ml DOP in the drinking water or with vehicle alone before the bone marrow transfer. Data are representative 
of at least three independent experiments with at least five mice (means ± SEM). Mice were 33 ± 5 d old and sex matched. RNA levels were normalized to 
VE-cadherin expression and expressed relative to values from vehicle-treated controls (=1, as indicated). Bone marrow transfers were done 1 d after 
FTY720 or DOP treatments were stopped. **, P < 0.01; and ***, P < 0.001.
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depending on the quantity and possibly also the quality of im-
migrated ETPs. This intrathymic signal regulates the periodic-
ity of thymic P-selectin and CCL25 expression. Mouse strains 
with reduced ETP numbers, such as IL-7R/, RAG-1/, 
PSGL-1/, and C2GnT1/ mice, have no periodic expres-
sion in thymic P-selectin and CCL25. The second mecha-
nism triggers a feedback signal depending on the size of the 
peripheral lymphocyte pool and is active especially under 
acute conditions affecting the intensity of Psel/CCL25 ex-
pression. The thymic vascular gates thus integrate both feed-
back signals and control the entry of new TCPs into the 
thymus by adjusting the amount and periodicity of expres-
sion of recruitment molecules on thymic endothelial cells. 
These results provide new insights into the mechanisms that 
regulate  periodic  TCP  importation  into  the  thymus  and 
demonstrate that the thymus responds to internal and exter-
nal cues to regulate T cell formation.
MATERIALS AND METHODS
Mice.  C57BL/6  (CD45.2),  congenic  C57BL/6  (CD45.1),  PSGL-1/ 
(B6.Cg-Selplgtm1Fur), Psel/, IL7R/, and RAG-1/ mice, all back-
crossed onto a C57BL/6 background, were purchased from the Jackson 
Laboratory. C2GnT1/ mice were backcrossed onto C57BL/6 mice for 
at least eight generations (obtained from J. Marth, Howard Hughes Medi-
cal Institute, University of California, San Diego, La Jolla, CA) (5), and 
were maintained and bred at the specific pathogen-free animal facility at 
the Biomedical Research Centre. For time-course experiments, only fe-
male mice were used. All animal experiments were performed according to 
institutional guidelines and were approved by the Animal Care Committee 
of the University of British Columbia.
Tissue extraction. Mice were sacrificed and perfused with PBS, 5 mM 
EDTA. Single-cell suspensions of peripheral lymph nodes and spleens were 
prepared by squeezing tissues through a mesh. Thymic cell suspensions were 
obtained by gently squeezing the thymus between two frosted glass slides 
and washing it several times with RPMI 1640, 2% FCS, 2 mM EDTA. The 
thymocyte-containing suspension fraction was filtered and kept for flow cy-
tometry analysis. The remaining nonsuspension fraction was either directly 
processed for qrtPCR or flow cytometry analysis, or stored at 80°C.
Flow cytometry and cell sorting. Cell suspensions were stained in stain-
ing buffer (PBS, 2% FCS, 2 mM EDTA) with titrated amounts of the anti-
bodies specified (Table S1). Samples were analyzed on a flow cytometer 
(FACSCalibur or LSRII; BD), and cell sorting was performed on a FACS-
Vantage or FACSAria (BD). Data were analyzed with FlowJo software (Tree 
Star, Inc.). Where required, a fixed number of reference beads (Invitrogen) 
were added per sample. The 10-µm latex beads were distinguished from cells 
by sideward scatter/forward scatter characteristics. Cell and bead numbers 
were determined by flow cytometry. Absolute cell numbers in the sample 
were calculated based on the determined cell/bead ratio and the known 
number of used beads and sample volume.
Flow cytometry analysis for thymocyte subsets. Thymus suspension 
cells were stained with a lineage marker mix consisting of biotinylated anti-
bodies (Table S1) against CD19, B220, CD3, CD4, CD8, Gr-1, CD11c, 
CD11b, Ter119, NK1.1, and /TCR, and were detected by PE-Cy7– or 
PE-Cy5–conjugated streptavidin (SA). Resolving DN subset distribution 
was achieved by additional staining for CD25 and CD44 antibodies. For 
ETP analysis, cells were furthermore stained with Sca-1 and cKit antibod-
ies. For mature thymocyte subset analysis, cells were stained with CD4, 
CD8, CD24, biotinylated L-selectin (detected with PE-Cy5–SA), Qa-2, 
and CD69 antibodies.
endothelial cells are also involved in S1P homeostasis by re-
moving S1P from circulation and/or releasing it into circula-
tion (18, 34–36, 45). Although they do not produce S1P, 
platelets have been shown to store and release large amounts 
of S1P (46) and may thus contribute to S1P homeostasis. We 
hypothesize that lymphocytes indirectly modulate S1P pro-
duction or degradation by cytokine release or by direct inter-
action with cells that control S1P homeostasis. Interaction of 
peripheral lymphocytes with thymic endothelial cell–expressed 
P-selectin and, thus, a direct signaling through thymic P-
selectin can, however, be excluded as a possible feedback 
mechanism, as resting peripheral lymphocytes do not ex-
press functional P-selectin ligand (47).
Based on our data, we propose a model in which thymic 
Psel/CCL25 expression and, consequently, thymic TCP re-
ceptivity are controlled by two feedback mechanisms. The 
first mechanism active under homeostatic conditions trig-
gers a feedback signal from the thymic perivascular region, 
Figure 10.  Plasma S1P levels are modulated by the size of the  
peripheral lymphocyte pool. (a) S1P level in plasma of WT mice 2 d after 
in vivo depletion of CD4 and CD8 T cells by i.p. injection of depleting  
antibodies measured by LC-MS/MS. Control mice received saline only.  
(b) Plasma S1P level in PSGL-1–deficient mice 2 d after adoptive transfer of 
WT B cells, T cells, or a 1:1 mix of T and B cells determined by LC-MS/MS. 
Data are representative of two independent experiments with at least four 
mice (means ± SEM). Mice were sex matched and 42 ± 2 d old. *, P < 0.05.JEM VOL. 206, April 13, 2009 
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Real-time  PCR. Crudely depleted thymic stromal tissue or sorted cell 
populations were obtained as described. RNA was extracted using TRIzol 
solution, according to the manufacturer’s instruction. The quality and quan-
tity of total RNA was assessed using a Nanodrop spectrometer (ND-1000; 
Thermo Fisher Scientific). 1 µg of total RNA was treated with DNase and 
reverse transcribed using random hexamers and Revert Aid H Minus M-
MuLV reverse transcription (all from Fermentas), according to manufacturer’s 
instructions. Gene expression was quantified using the primers/probes listed 
in Table S2. qrtPCR reactions were performed using TaqMan gene expres-
sion or SYBR green PCR master mix and run on a real-time PCR system 
(HT7900; all from Applied Biosystems). Relative mRNA expression ratios 
were calculated using the 7000 SDS relative quantification software (Applied 
Biosystems) or the REST software tool (51), as previously described.
Adoptive transfer. Lymph node cell suspensions from CD45.1 congenic 
mice were either directly injected into recipients or enriched for T or B 
cells by negative depletion using anti–rat IgG–coupled magnetic beads (In-
vitrogen). For T cell enrichment, cells were labeled with rat IgG antibodies 
against mouse CD19, MHC II, CD11b, and Gr-1, and were subsequently 
negatively depleted using anti–rat IgG–coupled magnetic beads. Accord-
ingly, B cells were enriched from spleen suspension cells using rat IgG anti-
bodies against mouse CD43, CD11b, MHC II, CD3, and Gr-1. Purities of 
target populations assessed by flow cytometry were generally >90%. 20 × 
106 cells in HBSS were injected i.v. into recipients (CD45.2). 3 d after 
adoptive transfer, one cohort of recipient mice was analyzed for donor chi-
merism (CD45.1), S1P level, and thymic P-selectin expression. The other 
cohort received a bone marrow transplant from a CD45.1/2 congenic do-
nor to test for thymic receptivity. Thymic chimerism was assessed 3 wk after 
bone marrow transfer by flow cytometry.
S1P measurement: LC-MS/MS. S1P levels in blood plasma and lym-
phoid tissues were assessed by LC-MS/MS, as previously described (35). In 
brief, platelet-poor plasma was obtained from blood drawn by cardiac punc-
ture. The plasma samples were diluted with acetonitrile to a final concentra-
tion of 20%. The thymus, six lymph nodes, and spleen were homogenized 
in 4× the volume (assuming a tissue density of 1 g/ml) of 80% acetonitrile. 
All samples were processed together with 60 ng/ml of internal standard (iso-
tope-labeled  S1P,  D-erythro-sphingosine-1-phosphate-13C2D2;  Toronto 
Research Chemicals). After centrifugation, supernatants were analyzed on a 
hybrid linear ion trap LC-MS/MS system (Q Trap; Applied Biosystems) 
coupled to an HPLC system (LC Packings) via a Turbo Ion Spray source 
(Applied Biosystems). Sample separation was performed over a 1 × 50 mm 
ZORBAX Eclipse XDB-C18 MicroBore column (particle size = 3.5 µm; 
Agilent Technologies) at the flow rate of 0.2 ml/min using the following 
gradient: wash column with a mixture of 50% A (water/methanol/acetic 
acid [69:30:1 vol/vol/vol] containing 5 mM ammonium acetate) and 50% B 
(methanol/acetic acid [99:1 vol/vol] containing 5 mM ammonium acetate) 
for 2 min, then apply a linear gradient to 100% B over 4 min, hold 100% B 
for 2 min, and reequilibrate column with 50% B for 2 min. For the detection 
of both S1P and internal standard, the Q Trap instrument was operated in 
positive mode with the ion spray voltage set at 5,000 V and the source tem-
perature set at 400°C. Other MS/MS parameter settings, such as declustering 
potential and collision energy, were optimized for S1P and internal standard, 
respectively. The elution of S1P and internal standard were monitored using 
the multiple reaction monitoring (MRM) mode. The MRM transition   
(Q1/Q3) settings for S1P and internal standard were 380/264.2 and 384/268.2,   
respectively. Data were acquired and processed using Analyst 1.4.2 software 
(Applied Biosystems).
Intrathymic FITC labeling. Intrathymic FITC labeling was performed as 
previously  described  (52).  In  brief,  10  µl  of  a  2-mg/ml  FITC  (Sigma- 
Aldrich) solution in PBS was directly injected into each thymic lobe of anes-
thetized mice using a Stepper (Tridek). The incision was closed with surgical 
clips,  and  mice  were  sacrificed  36  h  after  FITC  injection.  Numbers  of 
FITC+CD4+Lsel+ and FITC+CD8+Lsel+ positive cells were determined in 
Analysis and sorting of thymic endothelial and epithelial cells. For 
sorting, individual thymi were successively digested in 0.2 mg/ml collage-
nase and 0.2 mg/ml collagenase/dispase (Roche) in RPMI 1640 containing 
0.02 mg/ml DNase (Sigma-Aldrich) at 37°C, washed, and filtered through a 
100-µm mesh (Thermo Fisher Scientific), as previously described (48). Cells 
were enriched for stromal and endothelial cells by density centrifugation on 
a discontinuous Percoll gradient (GE Healthcare), as previously described 
(bottom layer  = 1.115 g/ml; middle layer  =1.06 g/ml; top layer = PBS) 
(49). Cells recovered from the upper interface were washed and stained with 
antibodies against CD45, CD31, CD144, G8.8, and Ly51. Cells were nega-
tively gated on CD45; medullary epithelial cells were defined as CD45G8.8+, 
Ly51int; cortical epithelial cells were defined as CD45G8.8+, Ly51hi; and 
endothelial cells were defined as CD45CD31+, CD144+ positive cells (50). 
Cells were sorted on a FACSVantage and directly sorted into TRIzol LS 
(Invitrogen) for RNA extraction. For analysis of stromal and endothelial cell 
numbers, thymi were gently squeezed between two frosted glass slides and 
agitated in RPMI 1640 for 30 min, replacing the supernatant every 10 min. 
Thymic tissues were then subjected to enzymatic digestion, as described, to 
obtain a single-cell suspension. Cells were collected, washed, filtered through 
a 100-µm mesh, and resuspended in 1 ml of staining buffer containing a fixed 
number of reference beads to allow for calculation of absolute cell numbers 
(see Flow cytometry and cell sorting). Cells were stained with the antibodies 
listed and were analyzed using a LSRII flow cytometer.
Analysis of P-selectin protein expression on thymic endothelial cells. 
Single-cell suspensions from thymi, obtained as described, were stained with 
antibodies against CD45, P-selectin, CD31, and CD144, and were analyzed 
by flow cytometry. Forward and sideward light scatter settings were adjusted 
to exclude dead cells and platelets. The cells were negatively gated on CD45 
to exclude hematopoietic cells and were positively gated for the endothelial 
markers CD31 and CD144. DP cells were analyzed for the frequency of high 
P-selectin–expressing cells, thereby excluding possible skewing of the results 
by different thymic size and relative endothelial content.
Short-term receptivity. Short-tern receptivity was determined by i.v. in-
jection of fluorescent-labeled cells, as previously described (3). In brief, WT 
bone marrow cells were labeled with 2.5 µM CFSE (Invitrogen) for 5 min 
at room temperature in HBSS. After staining, 40 million cells were i.v. in-
jected into a nonirradiated recipient. 24 h after injection, recipients were 
sacrificed, bled, and perfused. Thymi were removed, weighed, and mechan-
ically dissociated to obtain single-cell suspensions, as described in Tissue ex-
traction. Blood samples were treated as described in Blood cell count by flow 
cytometry. Thymic cell suspensions were stained with lineage markers, as 
described. After staining, cells were resuspended in 1 ml of staining buffer 
containing 105 reference beads (see Flow cytometry and cell sorting)
Sorting and i.v. injection of TN1–3 subsets. Cell suspensions from up 
to 8–10 thymi were pooled and labeled with the described lineage marker 
mix. Lineage marker–positive cells were depleted with SA-coupled magnetic 
beads using the “depletes” program on an AutoMacs system (all from Miltenyi 
Biotec). Lineage marker–negative cells were stained with antibodies against 
CD25 and CD44, and were FACS sorted on a FACSVantage. TN1 (CD44+, 
CD25), TN2 (CD44+, CD25+), and TN3 (CD44, CD25+) cells were col-
lected. The purity of the sorted population was >95%. 5,000 TN cells of each 
subset together with 106 IL-7R/ splenocytes were i.v. injected into nonir-
radiated IL-7R/ recipients. 12d after bone marrow transfer, recipient mice 
were sacrificed, the thymus and blood were analyzed for donor chimerism, 
and thymi were additionally analyzed for Psel RNA expression.
Blood cell count by flow cytometry. Mice were bled from the saphe-
nous vein, and 15 µl of peripheral blood was stained with anti-CD4 and   
-CD8 antibodies. 105 reference beads were added per sample. After red 
blood cell lysis, samples were analyzed by flow cytometry. Cell numbers per 
microliters of blood were calculated based on the cell/bead ratio (see Flow 
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Statistics. Data are presented as mean values and error bars are presented as 
SEM. The statistical significance of the data was assessed using an unpaired, 
two-tailed Student’s t test (*, P < 0.05; **, P < 0.01; ***, P < 0.001). Sta-
tistics were calculated using the SPSS 16 statistics software for Macintosh.
Online supplemental material. Fig. S1 shows thymic cellularity of the 
mouse strains used. Fig. S2 shows the time course of P-selectin RNA expres-
sion in spleens of WT, C2GnT1/, and PSGL-1/ mice. Fig. S3 shows 
the results of TN1, TN2, and TN3 injections into IL-7R/ mice. Fig. S4 
shows the RNA level of S1P1R, KLF2, and S1P-lyase in thymocyte subsets 
of WT, C2GnT1/, and PSGL-1/ mice. Fig. S5 shows the efficacy of 
peripheral T cell depletion in WT mice or boost in PSGL-1/ mice. Fig. 
S6 shows the efficacy of FTY720 treatment. Fig. S7 shows the efficacy of 
DOP treatment. Table S1 shows the primers used, and Table S2 shows the 
antibodies used. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20082502/DC1.
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